Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease [NA]

View source ↗

Summary

A clinical trial evaluating the safety and efficacy of a nucleus pulposus allograft for degenerative disc disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nucleus Pulposus Allograft

Snippet

Sponsor: VIVEX Biologics, Inc. | Conditions: Degenerative Disc Disease, Disc Degeneration | NA | Status: RECRUITING